Oragenics, Inc.
OGEN
$0.175
-$0.0036-2.02%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | 1.67M | 879.00K | 906.80K | 663.40K | 11.04M |
| Gross Profit | -1.67M | -879.00K | -906.80K | -663.40K | -11.04M |
| SG&A Expenses | 1.69M | 1.56M | 1.40M | 1.80M | 1.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.36M | 2.44M | 2.31M | 2.46M | 12.80M |
| Operating Income | -3.36M | -2.44M | -2.31M | -2.46M | -12.80M |
| Income Before Tax | -3.35M | -2.46M | -2.31M | -2.45M | -12.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.35M | -2.46M | -2.31M | -2.45M | -12.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.35M | -2.46M | -2.31M | -2.45M | -12.75M |
| EBIT | -3.36M | -2.44M | -2.31M | -2.46M | -12.80M |
| EBITDA | -3.35M | -2.43M | -2.30M | -2.45M | -12.80M |
| EPS Basic | -0.28 | -0.38 | -0.51 | -0.70 | -4.92 |
| Normalized Basic EPS | -0.18 | -0.24 | -0.32 | -0.44 | -3.08 |
| EPS Diluted | -0.28 | -0.38 | -0.51 | -0.70 | -4.92 |
| Normalized Diluted EPS | -0.18 | -0.24 | -0.32 | -0.44 | -3.08 |
| Average Basic Shares Outstanding | 11.92M | 6.53M | 4.53M | 3.50M | 2.59M |
| Average Diluted Shares Outstanding | 11.92M | 6.53M | 4.53M | 3.50M | 2.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |